- HPLC method development for the evaluation of a novel drug candidate from the group of aroylhydrazone iron chelators (2-pyridylcarboxaldehyde 2-thiophencarboxyl hydrazone-PCTH) in rabbit plasmaPublication without faculty affiliation
- Dose-dependence study of a novel iron chelator PCTH in a model of catecholamine cardiotoxicityPublication without faculty affiliation
- The novel iron chelator, 2-pyridylcarboxaldehyde-2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity2009 | Central Library of Charles University
- The novel iron chelator, 2-pyridylcarboxaldehyde-2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity2009 | First Faculty of Medicine
- Iron chelators in myocardial ischemia-reperfusion - comparison of endogenous lactoferrin with synthetic PCTHPublication without faculty affiliation
- The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity +12009 | Faculty of Medicine in Hradec Králové
- The novel iron chelator, 2-pyridylcarboxaldehyde-2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity2009 | Faculty of Pharmacy in Hradec Králové
- The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium2024 | Second Faculty of Medicine
- Effects of iron chelators on acute isoprenaline cardiotoxicityPublication without faculty affiliation